Evidence map›Paper›PMID 27939641›Full record

ArticleAmerican journal of human genetics2017

Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.

Dong-Chuan Guo, Xue-Yan Duan, Ellen S Regalado, Lauren Mellor-Crummey, Callie S Kwartler, Dong Kim, Kenneth Lieberman, Bert B A de Vries, Rolph Pfundt, Albert Schinzel and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Characteristics of Asian patients with Fibromuscular Dysplasia: a systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. An Overview of Genetics of Moyamoya: BeyondInternational journal of molecular sciences · 2026
    Review
  8. The genetics of hypertension.Nature reviews. Nephrology · 2026
    Review
  9. Article
  10. Immature Acta2Nature communications · 2025
    Article
  11. It Takes a Village of Chromatin Remodelers to Regulate rDNA Expression.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Epigenetic regulation ofAutophagy · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 4 countries.

Dong-Chuan GuoDepartment of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Xue-Yan DuanDepartment of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Ellen S RegaladoDepartment of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Lauren Mellor-CrummeyDepartment of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Callie S KwartlerDepartment of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Dong KimDepartment of Neurosurgery, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Kenneth LiebermanPediatric Nephrology, Joseph M. Sanzari Children's Hospital, Hackensack, NJ 07601, USA.
Bert B A de VriesDepartment of Human Genetics, Radboud University Nijmegen Medical Center, 6525 Nijmegen, the Netherlands.
Rolph PfundtDepartment of Human Genetics, Radboud University Nijmegen Medical Center, 6525 Nijmegen, the Netherlands.
Albert SchinzelInstitute of Medical Genetics, University of Zurich, 8006 Zurick, Switzerland.
Dieter KotzotDepartment of Medical Genetics, Molecular and Clinical Pharmacology of the Medical University of Innsbruck, 6020 Innsbruck, Austria.
Xuetong ShenDepartment of Epigenetics &Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Min-Lee YangDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
University of Washington Center for Mendelian Genomics
Michael J BamshadDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Deborah A NickersonDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Heather L GornikDepartment of Cardiovascular Medicine, Cleveland Clinic Heart and Vascular Institute, Cleveland, OH 44195, USA.
Santhi K GaneshDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Alan C BravermanDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Dorothy K GrangeDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Dianna M MilewiczDepartment of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA. Electronic address: dianna.m.milewicz@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USRadboud University Nijmegen · NLUniversity of Michigan · USUniversity of Washington · USWashington University in St. Louis · USCleveland Clinic · USInnsbruck Medical University · ATSt. Joseph’s Children’s Hospital · USThe University of Texas Health Science Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of Zurich · CH

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Pathology and Molecular Imaging CoreP01HL110869 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2016
$10.4M
Genetic Predisposition To Thoracic Aortic Aneurysms/DissectionsR01HL109942 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2023
$7.5M
Post-translational Modification of ActinR01GM093104 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHEN, XUETONG · 2010 to 2019
$2.8M
NCATS NIH HHS UL1 TR000371NCATS NIH HHS UL1 TR000439NCRR NIH HHS UL1 RR024989NHGRI NIH HHS U54 HG006493NHGRI NIH HHS UM1 HG006493NHLBI NIH HHS P01 HL110869NHLBI NIH HHS R01 HL109942NIGMS NIH HHS R01 GM093104
6 · The paper itself

Abstract

Fibromuscular dysplasia (FMD) is a heterogeneous group of non-atherosclerotic and non-inflammatory arterial diseases that primarily involves the renal and cerebrovascular arteries. Grange syndrome is an autosomal-recessive condition characterized by severe and early-onset vascular disease similar to FMD and variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities. Exome-sequencing analysis of DNA from three affected siblings with Grange syndrome identified compound heterozygous nonsense variants in YY1AP1, and homozygous nonsense or frameshift YY1AP1 variants were subsequently identified in additional unrelated probands with Grange syndrome. YY1AP1 encodes yin yang 1 (YY1)-associated protein 1 and is an activator of the YY1 transcription factor. We determined that YY1AP1 localizes to the nucleus and is a component of the INO80 chromatin remodeling complex, which is responsible for transcriptional regulation, DNA repair, and replication. Molecular studies revealed that loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF-β-driven differentiation of smooth muscle cells. Identification of YY1AP1 mutations as a cause of FMD indicates that this condition can result from underlying genetic variants that significantly alter the phenotype of vascular smooth muscle cells.

Indexed as

MutationAdolescentAdultBone and BonesBrachydactylyCell Cycle CheckpointsCell Cycle ProteinsExomeFemaleFibromuscular DysplasiaGenes, RecessiveHeterozygoteHomozygoteHumansLearning DisabilitiesMaleCell Cycle ProteinsNuclear ProteinsTranscription FactorsYY1AP1 protein, human

Identifiers

PMID27939641
PMCPMC5223026
OpenAlexW2560104334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.